XERIS BIOPHARMA HOLDINGS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $14.4M | $19.5M |
| FY2020 | $87.0M | $33.8M | $37.6M |
| FY2021 | $88.1M | $95.2M | $67.3M |
| FY2022 | $187.1M | $45.2M | $122.0M |
| FY2023 | $190.9M | $-6.8M | $67.4M |
| FY2024 | $217.0M | $-29.6M | $71.6M |
| FY2025 | $220.3M | $13.7M | $111.0M |